TY - JOUR
T1 - Stem cell therapy trials
T2 - a call for standardization.
AU - Miller, Leslie W.
PY - 2008/9
Y1 - 2008/9
N2 - There are currently 25 new clinical cellular therapy trials in progress for cardiovascular disease in the US, and a similar number ongoing in Europe. The lack of standardization in cell isolation, preparation, storage, and time and localization of delivery, present clear hurdles to this growing field. This emphasizes the need for an organized task force to work closely with the FDA to agree upon standardized methods with the end result being improvements in patient care and enhanced knowledge in the field.
AB - There are currently 25 new clinical cellular therapy trials in progress for cardiovascular disease in the US, and a similar number ongoing in Europe. The lack of standardization in cell isolation, preparation, storage, and time and localization of delivery, present clear hurdles to this growing field. This emphasizes the need for an organized task force to work closely with the FDA to agree upon standardized methods with the end result being improvements in patient care and enhanced knowledge in the field.
UR - http://www.scopus.com/inward/record.url?scp=70350704372&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350704372&partnerID=8YFLogxK
U2 - 10.1007/s12265-008-9042-0
DO - 10.1007/s12265-008-9042-0
M3 - Article
C2 - 20559914
AN - SCOPUS:70350704372
SN - 1937-5387
VL - 1
SP - 185
EP - 187
JO - Journal of cardiovascular translational research
JF - Journal of cardiovascular translational research
IS - 3
ER -
